Literature DB >> 16895622

Doxapram and aminophylline on bispectral index under sevoflurane anaesthesia: a comparative study.

C-C Wu1, C-S Lin, G-J Wu, Y-H Lin, Y-W Lee, J-Y Chen, M S Mok.   

Abstract

BACKGROUND AND
OBJECTIVE: To evaluate and compare the effect of two clinically available central nervous system stimulants, namely doxapram and aminophylline on arousal from sevoflurane anaesthesia and bispectral index.
METHODS: This randomized, double-blind, placebo-controlled, prospective study was conducted in 90 adult females, ASA I-II, scheduled for elective lower abdominal surgeries at Taipei Medical University Hospital. At 5 min before the completion of surgery, under sevoflurane anaesthesia, patients were divided into three groups to receive doxapram 1 mg kg(-1), aminophylline 2 mg kg(-1) or saline placebo intravenous. Standard vital signs, end-tidal CO(2), end-expiratory sevoflurane concentration, bispectral index and neuromuscular blockade were measured plus clinical parameters of recovery from general anaesthesia.
RESULTS: Compared with the control group, patients receiving doxapram or aminophylline showed a similarly faster recovery from sevoflurane anaesthesia correlated with increase in bispectral index.
CONCLUSION: Intravenous administration of doxapram 1 mg kg(-1) or aminophylline 2 mg kg(-1) hastened the early recovery from sevoflurane anaesthesia. The arousal effect of aminophylline and doxapram appears to be similar.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16895622     DOI: 10.1017/S0265021506001220

Source DB:  PubMed          Journal:  Eur J Anaesthesiol        ISSN: 0265-0215            Impact factor:   4.330


  1 in total

1.  The effects of Aminophylline on clinical recovery and bispectral index in patients anesthetized with total intravenous anaesthesia.

Authors:  Sina Ghaffaripour; Mohammad Bagher Khosravi; Ashkan Rahimi; Mohammad Ali Sahmedini; Abdolhamid Chohedri; Hilda Mahmoudi; Mohammad Reza Kazemi
Journal:  Pak J Med Sci       Date:  2014 Nov-Dec       Impact factor: 1.088

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.